These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 3802030)

  • 21. Squamous differentiation in patients with superficial bladder urothelial carcinoma is associated with high risk of recurrence and poor survival.
    Li G; Yu J; Song H; Zhu S; Sun L; Shang Z; Niu Y
    BMC Cancer; 2017 Aug; 17(1):530. PubMed ID: 28789622
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Proton beam therapy for invasive bladder cancer: a prospective study of bladder-preserving therapy with combined radiotherapy and intra-arterial chemotherapy.
    Hata M; Miyanaga N; Tokuuye K; Saida Y; Ohara K; Sugahara S; Kagei K; Igaki H; Hashimoto T; Hattori K; Shimazui T; Akaza H; Akine Y
    Int J Radiat Oncol Biol Phys; 2006 Apr; 64(5):1371-9. PubMed ID: 16580495
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Conservative treatment of invasive bladder carcinoma by transurethral resection, protracted intravenous infusion chemotherapy, and hyperfractionated radiotherapy: long term results.
    Danesi DT; Arcangeli G; Cruciani E; Altavista P; Mecozzi A; Saracino B; Orefici F
    Cancer; 2004 Dec; 101(11):2540-8. PubMed ID: 15481058
    [TBL] [Abstract][Full Text] [Related]  

  • 24. T2a transitional cell carcinoma of the bladder: long-term experience with intravesical immunoprophylaxis with bacillus Calmette-Guerin.
    Volkmer BG; Gschwend JE; Maier SH; Seidl-Schlick EM; Bach D; Romics I
    J Urol; 2003 Mar; 169(3):931-4; discussion 934-5. PubMed ID: 12576815
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bladder carcinoma treated by irradiation and surgery: interval report.
    DeWeerd JH; Colby MY
    J Urol; 1973 Mar; 109(3):409-13. PubMed ID: 4632525
    [No Abstract]   [Full Text] [Related]  

  • 26. [T1G3 bladder tumors: 5 years later].
    Pegoraro C; Bondovalli C; Dall'Oglio B; Schiavon L; Luciano M; Parma A
    Arch Ital Urol Androl; 1996 Feb; 68(1):35-8. PubMed ID: 8664919
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effect of intravesical mitomycin C on recurrence of newly diagnosed superficial bladder cancer: a further report with 7 years of follow up.
    Tolley DA; Parmar MK; Grigor KM; Lallemand G; Benyon LL; Fellows J; Freedman LS; Grigor KM; Hall RR; Hargreave TB; Munson K; Newling DW; Richards B; Robinson MR; Rose MB; Smith PH; Williams JL; Whelan P
    J Urol; 1996 Apr; 155(4):1233-8. PubMed ID: 8632538
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Intra-arterial chemotherapy for invasive bladder cancer].
    Ozono S; Kim SC; Takashima K; Tani Y; Okajima E; Hirao Y; Maruyama Y; Iwai A; Samma S; Momose H
    Hinyokika Kiyo; 1999 Feb; 45(2):133-7. PubMed ID: 10212788
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Therapy and follow-up of bladder cancer].
    Meyer D; Schmid HP; Engeler DS
    Wien Med Wochenschr; 2007; 157(7-8):162-9. PubMed ID: 17492413
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Concomitant continuous infusion chemotherapy and radiation.
    Rotman M; Aziz H
    Cancer; 1990 Feb; 65(3 Suppl):823-35. PubMed ID: 2105833
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The incidence of bladder tumor recurrences after transurethral resection during combined treatment].
    Matveev BP; Shipilov VI; Gotsadze DT; Abdushelishvili KO; Pirtskhalaishvili GG
    Urol Nefrol (Mosk); 1990; (3):53-6. PubMed ID: 2396341
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of combined therapy using balloon-occluded arterial infusion of cisplatin and hemodialysis with concurrent radiation for locally invasive bladder cancer.
    Azuma H; Kotake Y; Yamamoto K; Sakamoto T; Kiyama S; Ubai T; Inamoto T; Takahara K; Matsuki M; Segawa N; Shibahara N; Katsuoka Y
    Am J Clin Oncol; 2008 Feb; 31(1):11-21. PubMed ID: 18376222
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Combined radiation and chemotherapy for invasive transitional-cell carcinoma of the bladder: a prospective study.
    Housset M; Maulard C; Chretien Y; Dufour B; Delanian S; Huart J; Colardelle F; Brunel P; Baillet F
    J Clin Oncol; 1993 Nov; 11(11):2150-7. PubMed ID: 8229129
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bladder carcinoma treated by irradiation and surgery: interval report.
    Deweerd JH; Colby MY
    Trans Am Assoc Genitourin Surg; 1972; 64():74-8. PubMed ID: 4654525
    [No Abstract]   [Full Text] [Related]  

  • 35. Neoadjuvant combined microwave induced local hyperthermia and topical chemotherapy versus chemotherapy alone for superficial bladder cancer.
    Colombo R; Da Pozzo LF; Lev A; Freschi M; Gallus G; Rigatti P
    J Urol; 1996 Apr; 155(4):1227-32. PubMed ID: 8632537
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The case for radiotherapy with or without chemotherapy in high-risk superficial and muscle-invading bladder cancer.
    Zietman AL; Shipley WU; Heney NM; Althausen AF
    Semin Urol Oncol; 1997 Aug; 15(3):161-8. PubMed ID: 9394911
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Acute and late morbidity in the treatment of advanced bladder carcinoma with accelerated radiotherapy, carbogen, and nicotinamide.
    Hoskin PJ; Rojas AM; Phillips H; Saunders MI
    Cancer; 2005 Jun; 103(11):2287-97. PubMed ID: 15834926
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cisplatin, 5-fluorouracil, mitomycin C, and concurrent radiation therapy with and without esophogectomy for esophageal carcinoma.
    Stewart FM; Harkins BJ; Hahn SS; Daniel TM
    Cancer; 1989 Aug; 64(3):622-8. PubMed ID: 2501018
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High grade superficial (G3t1) transitional cell carcinoma of the bladder treated with intravesical Bacillus Calmette-Guerin (BCG).
    Pansadoro V; Emiliozzi P; depaula F; Scarpone P; Pizzo M; Federico G; Martini M; Pansadoro A; Sternberg CN
    J Exp Clin Cancer Res; 2003 Dec; 22(4 Suppl):223-7. PubMed ID: 16767936
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intravesical mitomycin C combined with hyperthermia for patients with T1G3 transitional cell carcinoma of the bladder.
    Halachmi S; Moskovitz B; Maffezzini M; Conti G; Verweij F; Kedar D; Sandri SD; Nativ O; Colombo R
    Urol Oncol; 2011; 29(3):259-64. PubMed ID: 19395285
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.